IBIO iBio Corp Year-over-year net earnings per share growth for the last 12 months
AI and robotics-driven antibody design automation reduces manual labor but creates volatility, as highlighted by the quarterly EPS dynamics for iBio, Inc. (IBIO). The current value of the parameter is 54.30. Meanwhile, management is transforming the business into an oncology therapy search engine while raising capital. Strong partner confidence in the innovative precision search platform confirms the status of iBio, Inc. (IBIO) as a promising market player.
Summary analytical data breakdowns for iBio Corporation (IBIO)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
- earnings and market multiples details:
IBIO - Final Profit|Projected Future Earnings iBio, Inc.|IBIO - Business Payback Period|Future Price to Earnings iBio Corp|IBIO - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple iBio Corp|IBIO - Operating profit before deduction of amortization|Net earnings per share for the last 12 months iBio|IBIO - Net earnings per share for the last four quarters|Quarterly EPS earnings growth ibioinc.com|IBIO - Expected net earnings per share growth this year|Earnings growth forecast for next year iBio, Inc.
- company sales and revenue statistics:
Fundamental valuation:iBio - IBIO
Developing antibodies using the RubrYc AI engine requires significant investments in computing power, which directly impacts the financial efficiency of iBio, Inc. (IBIO). By analyzing the quarterly earnings per share chart, an investor tracks net income dynamics over three months, accounting for taxes and subsidies, which allows for the identification of hidden costs and an assessment of capital stability amid resource volatility.
Competitors of iBio, Inc. (IBIO)
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Celldex Corp CLDX|AUPH: Quarterly EPS earnings growth|BCRX (biocryst.com) - Year-over-year earnings per share growth for the last twelve months|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|Dianthus Therapeutics Inc (DNTH) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Pharvaris Corp (PHVS)|ABCL - Earnings per share growth in annualized terms for the last twelve months|Tourmaline Bio, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PGEN|Pharming Group - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Nektar Therapeutics Inc NKTR|Upstream Bio Corp (UPB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ZBIO|IMNM (Immunome, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months gossamerbio.com (GOSS)|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals, Inc.)|Year-over-year net earnings per share change for the last twelve months Septerna, Inc.|Quarterly EPS earnings growth PVLA (Pieris Pharmaceuticals Inc)|Year-over-year net earnings per share change for the last twelve months Savara Pharma (SVRA)|Rigel Pharmaceuticals - Quarterly EPS earnings growth|ANAB: Year-over-year earnings per share growth for the last twelve months|ATXS: Quarterly EPS earnings growth|ENGN - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months RAPT Therapeutics|Earnings per share growth in annualized terms for the last twelve months Aerovate JBIO|Year-over-year earnings per share growth for the last twelve months Aclaris Therapeutics (ACRS)|KYTX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences Ltd)|Year-over-year earnings per one share growth for the last 12 months CABA|Ventyx Bio - Quarterly EPS earnings growth|THTX - Quarterly EPS earnings growth|Avalo Therapeutics, Inc (AVTX) - Year-over-year earnings per share growth for the last twelve months|eledon.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Agenus Inc.|Year-over-year net earnings per share growth for the last 12 months Climb Bio Inc. (CLYM)|Quarterly EPS earnings growth ZURA|Quarterly EPS earnings growth aTyr Pharmaceuticals (ATYR)|Adagene Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months IMA|Shattuck Therapeutics - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Equillium, Inc. EQ|connectbiopharm.com (CNTB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Immunic|Year-over-year earnings per share growth for the last twelve months Atara Biotherapeutics, Inc.|Year-over-year net earnings per share growth for the last 12 months InflaRx GmbH (IFRX)|Year-over-year net earnings per share growth for the last 12 months XFOR (X4 Pharmaceuticals, Inc.)|Quarterly EPS earnings growth adicetbio.com (ACET)|Year-over-year earnings per share growth for the last twelve months Celularity CELU|INMB: Year-over-year earnings per share growth for the last 12 months|Barinthus Biotherapeutics - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months kezarlifesciences.com|SABS: Quarterly EPS earnings growth|AKTX - Year-over-year net earnings per share change for the last twelve months|ENLV (Enlivex Therapeutics Ltd) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months QTTB|Quarterly EPS earnings growth GOVX|Year-over-year net earnings per share change for the last twelve months edesabiotech.com|Year-over-year earnings per share growth for the last twelve months Carisma Therapeutics Inc. CARM|XTL Biopharmaceuticals Ltd (XTLB) - Earnings per share growth in annualized terms for the last twelve months|BOLT: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HCWB (HCW Biologics Inc.)|APVO: Quarterly EPS earnings growth|AIM - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Aditxt Inc.|Year-over-year earnings per share growth for the last 12 months GRI (GRI Bio Inc)|Quarterly EPS earnings growth XRTX|Year-over-year net earnings per share growth for the last 12 months Vyome Therapeutics HIND|Revelation Biosciences - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months CalciMedica, Inc. CALI|AFMD: Quarterly EPS earnings growth|ALLK (Allakos) - Year-over-year earnings per share growth for the last twelve months|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|IGM Bio (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iTeos Therapeutics, Inc. (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months TC BioPharm (Holdings) PLC TCBP|THRD (Third Harmonic Bio Inc) - Year-over-year net earnings per share trend for the last twelve months
